- Supported exchanges /
- ST /
- IDOGEN.ST
Idogen AB (IDOGEN ST) stock market data APIs
Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient's immune system from attacking biological agents, transplanted organs, and the body's own cells or tissues in Sweden. The company's advanced product candidate is IDO 8 that is designed for patients with severe haemophilia A, who have developed neutralizing antibodies against critical treatment with coagulation factor VIII. It also develops IDO T, a tolerogenic cell therapy to prevent organ transplant rejection primarily kidney transplantation; and IDO AID for the treatment of autoimmune diseases. The company was incorporated in 2008 and is headquartered in Lund, Sweden.
Idogen AB Financial Data Overview
| 0.1405 | |
| -0.3395 | |
| - | |
| 0.2505 | |
| -0.2095 | |
| 0.1205-0.1205 | |
| 12 786 K | |
| 104 M | |
| 771 K | |
| -0.0728 | |
| 1.7761 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Idogen AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 771 K
- EBITDA -42 910 000
- Earnings Per Share -0.38
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Idogen AB Earnings via APIs
- Latest Release 2023-05-09
- EPS/Forecast NaN
Get Idogen AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
